Results 251 to 260 of about 17,182,321 (391)

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

open access: yesNature Network Boston, 2018
J. Fraietta   +36 more
semanticscholar   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte   +10 more
wiley   +1 more source

Cell therapy [PDF]

open access: yesBone Marrow Transplantation, 2001
openaire   +1 more source

Precision sniper for solid tumors: CAR-NK cell therapy. [PDF]

open access: yesCancer Immunol Immunother
Li S   +8 more
europepmc   +1 more source

Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors [PDF]

open access: bronze, 1989
Helen Griffiths   +5 more
openalex   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

open access: yesMolecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy